PATENT CLAIM ANALYSIS

Application Number: 15755854
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["546", "193000"]

Abstract:
The present disclosure relates to a crystalline Forms A, B, and C of (R)—N-((4-methoxy-6-methyl-2-oxo-1,2-di-hydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide, each of which are useful as modulators the activity of histone methyl modifying enzymes. The present disclosure also provides pharmaceutically acceptable compositions comprising the crystalline forms and methods of using said compositions in the treatment of various disorders.

Claim (Index 30):
The method of  claim 29 , wherein the cancer is selected from breast cancer, prostate cancer, colon cancer, renal cell carcinoma, glioblastoma multiforme cancer, bladder cancer, melanoma, bronchial cancer, lymphoma, liver cancer, multiple myeloma, lymphoma, ovarian cancer, NSCL, pancreatic cancers, malignant rhabdoid tumor, synovial sarcoma, glioma.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 88.0
- Lexical Diversity: 1.51923
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11672536', '15344426', '13592389', '13248840', '14854760']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8017408358272621
- 35 USC 102 Novelty (BERT): 0.5377273415269167
- Combined Prediction Score: 0.7753394863972276
- Mean Citation Score: 351.66024000000016
- Max Citation Score: 364.6086
- Similarity Product: 176.792798101902

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test